Hims Testosterone Reviews: What Hims Actually Sells, What It Costs, and Whether the Evidence Holds Up

Hims testosterone reviews need one distinction: its current pill is compounded enclomiphene, not testosterone replacement therapy (TRT). The lowest advertised rate is $99 a month on a $990, 10-month upfront plan, before any lab credit. It may fit someone whose clinician recommends this approach; needing testosterone itself or near-term fertility care changes the choice.¹²

By TRT Provider Guide · Last verified: September 2026 · Sources checked September 14, 2026

Who is Hims best for — and who should start somewhere else?

Hims is worth considering when a clinician has assessed the cause of low testosterone and a compounded pill is an acceptable option. It is not the same choice as an FDA-approved testosterone prescription, and active fertility plans call for a fertility-focused evaluation first.¹³⁴

These are editorial fit judgments, not a diagnosis or eligibility screen. Hims' refusal of HSA/FSA payment is a separate issue from whether a specific expense can qualify for reimbursement.¹⁵

Public-source research. We did not buy treatment, complete an intake, or test Hims' clinical service. This page has not been medically reviewed. Links to Hims below are ordinary source links, not paid tracking links — we earn nothing if you choose Hims.

Affiliate disclosure: Male Excel and Taurus Meds are commercial partners of TRT Provider Guide. The provider links in this article are ordinary public-information links, not paid tracking links. A partnership does not establish that a provider is right for you. See our affiliate disclosure.

---

Here's the thing to settle before choosing Hims: its current testosterone treatment is not testosterone.

The product Hims sells as Testosterone Rx+ is compounded enclomiphene — a daily pill that tells your body to make more of its own testosterone. It does not add testosterone from outside. Hims says so on its own site: "Hims does not currently offer access to TRT injections." Pricing starts at $99 a month, but only on a 10-month plan paid upfront in full — a $990 plan value before any lab credit. The 3-month plan is $199 a month. Before treatment, there's a $94 lab kit, which Hims says is credited toward treatment if you're deemed eligible.¹²

That's the honest bottom line. Now here's the part that took us longer to untangle, and the part that actually decides whether this is worth your money: enclomiphene raises testosterone levels in clinical trials. Whether it makes you feel better is a separate question — and two different drug regulators reviewing earlier trials landed in the same uncomfortable place. Later research still needs to be read by drug, outcome and study population.⁶⁷⁸

We'll get to that. First, let's make sure you know what you're buying.

---

The right TRT provider is not the same for every person — it depends on whether low testosterone has been properly evaluated, your symptoms and health history, your fertility plans, your state, your insurance or cash-pay preference, your treatment-format preference, your budget, and whether online or in-person care is the better starting point. Some situations belong with primary care, urology, endocrinology, reproductive urology, or urgent or emergency care when the symptoms warrant it. Because a general answer cannot resolve those for you, use TRT Provider Guide's Find My TRT Path tool to map your situation to the right care route and the questions to ask before you pay.

The tool is educational. It does not diagnose low testosterone, decide eligibility, or promise you a prescription.

TRT Provider Guide is the independent decision resource for testosterone replacement therapy — helping U.S. adults understand how low testosterone is evaluated, compare online and local care models and providers, and choose the next step that fits their health needs, fertility plans, budget, state, and care preferences, with every material claim verified and dated.

This guide concerns U.S. adults considering Hims' men's low-testosterone service. It is not a guide to adolescent care, women's hormone care, gender-affirming treatment, or nonmedical testosterone use.

This page is educational information, not medical advice. Chest pain, severe shortness of breath, sudden vision or hearing changes, an erection lasting more than four hours, or thoughts of harming yourself need urgent in-person or emergency care — not a message queue in an app.⁹¹⁰

---

What is Hims testosterone, exactly?

Hims' testosterone program is built on compounded enclomiphene, a pill that stimulates the body's own testosterone production rather than replacing testosterone from outside. Hims also sells a separate product called Sex Rx + Testosterone Support, which contains tadalafil and supplements and no enclomiphene at all. Injectable testosterone and FDA-approved oral testosterone are listed on the Hims storefront as "Coming in 2026."¹¹¹

There are five offers or formulations in the table below. They are not the same, and mixing them up can send you toward the wrong treatment.

Product identities and published launch status observed on September 14, 2026. The first three rows describe compounded preparations, not FDA-approved finished products. Kyzatrex's approval does not establish availability through Hims.^11210111314

So what is enclomiphene? It's a selective estrogen receptor modulator, or SERM. In plain terms: your brain uses estrogen as a feedback signal to decide how much testosterone to tell your body to make. Enclomiphene blocks that signal. Your pituitary gland responds by releasing more luteinizing hormone (LH) and follicle-stimulating hormone (FSH) — the two messengers that tell your testicles to produce testosterone and sperm.⁴

That mechanism has one hard limit worth understanding before you spend anything. Enclomiphene requires a hormone system and testicles that can still respond to the message. If the problem is testicular failure — what doctors call primary hypogonadism — shouting louder doesn't repair the testicles. The cause of low testosterone needs a clinical evaluation; a low number alone does not show that a SERM is suitable.³⁴

Here's a useful test you can run yourself in about ten seconds. Open the Hims testosterone page and search it for the word "Coming." Two product cards will light up. Those are the two testosterone products. Everything else on the page is something different.¹

For the differences between actual testosterone formulations, see our TRT treatment options guide.

---

Why does Hims sell enclomiphene instead of testosterone?

Testosterone is a Schedule III controlled substance in the United States; enclomiphene is not a scheduled controlled substance. They follow different prescribing rules, but those rules do not establish why Hims chose its launch sequence.¹⁵⁷

Hims has not established that regulatory status caused the difference. Its announcement says enclomiphene access began in September 2025 and testosterone products were planned for 2026.¹⁶

Testosterone requires a valid prescription. Under the Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities (90 Fed. Reg. 61301), issued jointly by the DEA and HHS, appropriately authorized DEA-registered clinicians can prescribe controlled medicines through qualifying telemedicine encounters without a prior in-person medical evaluation when the rule's conditions are met. It took effect January 1, 2026 and is scheduled to expire December 31, 2026.¹⁷

For testosterone under this temporary pathway, that means a qualifying real-time audio-video encounter, a legitimate medical purpose, prescribing in the usual course of professional practice, and compliance with other federal and state requirements. It is not permission for any website to prescribe in every state, and a provider can still require an in-person examination.¹⁷

Enclomiphene is a prescription medicine, not a controlled-substance workaround. A compounded prescription still has to meet applicable prescribing, pharmacy and compounding requirements. Being outside the controlled-substance schedules does not make it FDA-approved or risk-free.¹⁴¹⁸

That's not a criticism. It's just the map.

---

When will Hims actually have testosterone?

Hims announced an exclusive collaboration with Marius Pharmaceuticals to offer Kyzatrex, an FDA-approved oral testosterone, on September 10, 2025, with a stated 2026 launch. As of September 14, 2026, both Injectable TRT and Oral TRT are still labeled "Coming in 2026" on the Hims storefront with a forward-looking-statement asterisk.¹⁶¹¹³

That's 369 days between the announcement and our check, with the public storefront still labeling the testosterone products as coming later.

Hims' own asterisk is honest about why that can happen: the expected launch is "subject to certain assumptions and factors, some of which may be outside of our control, and as such may be subject to change." Fair enough. Product launches slip.¹

Two dated facts matter here, but neither proves why the launch has not been confirmed:

• Hims' testosterone products are marked "Coming in 2026."¹
• The temporary federal pathway for qualifying remote controlled-substance prescribing is scheduled to expire December 31, 2026.¹⁷

We are not predicting anything. A later federal rule or extension could change that end date. It would not, by itself, confirm a Hims product launch.

What we're saying is simpler: if you're waiting for Hims to sell you real testosterone, the public pages we checked still do not give you a confirmed availability date. If your clinician recommends testosterone now, discuss a currently available prescribing and pharmacy option rather than relying on an announcement. That's the honest read.¹

Hims' launch press release also includes numerical claims about Kyzatrex results. Those refer to a different, FDA-approved testosterone product — not the compounded enclomiphene offer you can currently research through Hims. They cannot establish results for Testosterone Rx+.¹⁶¹³

---

How much does Hims testosterone actually cost?

Hims publishes three plan lengths for its enclomiphene treatment: $199 a month on a 3-month plan, $139 a month on a 5-month plan, and $99 a month on a 10-month plan paid upfront in full. Before treatment, there is a $94 initial lab kit, which Hims states is credited toward the cost of treatment if you are deemed eligible. Follow-up lab kits are stated to have no cost.²¹⁹¹

The advertised "$99" does not tell you the commitment. Here's the full ladder, from Hims' own published materials:

Rates published by Hims. Term totals are our arithmetic (199 × 3, 139 × 5, 99 × 10). None of these is a checkout quote — we did not complete an enrollment.²¹

Three things to take from that table.

First, the $99 is real — but it requires the largest upfront commitment of these three plans. To pay $99 a month you commit to ten months at a gross plan value of $990, with any lab credit accounted for separately. If you want to try it for a quarter first, the published rate is $199 a month. That's more than double the advertised monthly rate; the exact prescription still depends on the clinician.²¹

Second, the $94 is the price of finding out. Hims states it's credited toward treatment if you're eligible. That's a genuinely useful credit — but read the condition. If you're deemed eligible. Hims' general testing terms describe refunds as case-by-case, not as an automatic refund when a clinician declines to prescribe. Ask what happens to that $94 before you order the kit, and get the answer in writing.²²⁰

Third, don't annualize the rate and call it your bill. $99 × 12 = $1,188, but that's just a rate multiplied by twelve. It doesn't establish what you'll be charged, because a 10-month plan doesn't tell you what the renewal costs or when it processes. Keep three numbers separate in your head: the monthly rate, the months you're buying, and the amount that actually leaves your account today. They're three different things, and your written quote and checkout terms should show all three.²

What can you honestly calculate for the first year?

A complete first-year bill is not established by the public $99 rate. The missing pieces are the exact credit application, renewal processing date, renewal amount and any charges outside the quoted package. A 10-month term also does not, by itself, cover 12 months.

Use this cash-flow check rather than adding the lab kit twice:

If the full $94 credit reduces the $990 treatment term, the kit plus that first term totals $990, not $1,084: $94 + $990 − $94. That is conditional arithmetic, not a tested checkout quote. Without that credit, $94 + $990 would be $1,084; it is not a claim that Hims normally charges both in full.²

For that same upfront-plan scenario, first-year cash paid equals $94 + $990 − credit applied + later payments + other charges − refunds. Count only money paid or returned during the first 365 days. Do not call the result a complete quote until every term is known; cash paid can also buy medication extending beyond that first year.

For a broader comparison, our TRT cost guide separates treatment, testing, visits and pharmacy costs.

On payment methods, Hims is clear and it's bad news for some readers: Hims does not bill insurance, and its testosterone FAQ states it does not accept HSA or FSA plans as payment. That does not establish that you cannot later seek reimbursement for a qualified medical expense. IRS rules distinguish paying a provider from reimbursing yourself or submitting an eligible expense to a plan. Ask Hims for an itemized receipt and check the exact expense with your HSA/FSA administrator; do not assume the entire bundled plan qualifies.¹²⁰⁵

What a plan includes, per Hims: medication, a personalized treatment plan, ongoing lab work, unlimited messaging with your provider, and free shipping.¹⁹

Before you commit to any plan length, get the numbers in writing. Read Hims' published pricing guide, which lists all three plan rates. Then ask for the four things your quote needs to settle: what's charged today after any credit, what happens to the $94 if you're not prescribed, the exact date and amount of the next charge, and what's refundable at each stage. The full question sheet is further down this page.

---

What blood tests does Hims run, and are they good enough?

Hims requires lab testing before a provider can prescribe and describes an at-home kit with two Tasso upper-arm collection devices, with samples returned the same day to a CLIA-certified laboratory. Hims states the kit measures nine biomarkers: total testosterone, free testosterone, SHBG, estradiol, LH, FSH, PSA, albumin and hematocrit. Diagnostic guidance calls for appropriately repeated early-morning testosterone testing — not just two collection devices.¹¹⁹²¹

Let's define the ones that matter, quickly:

• Total testosterone — everything circulating in your blood, bound and unbound.
• Free testosterone — the portion not bound to proteins. It can help clarify the picture when total testosterone is borderline or SHBG is altered.³
• SHBG (sex hormone-binding globulin) — a protein that binds testosterone tightly. It helps explain why total and free testosterone can tell different stories.³
• LH and FSH — the two signals from your pituitary gland. These help a clinician assess whether the problem is in the signaling system or the testicles — a key question in whether a SERM could help. They do not replace a full cause evaluation or a semen analysis.³
• Hematocrit — the percentage of your blood that's red blood cells. Testosterone therapy can push it up.¹³
• PSA (prostate-specific antigen) — a prostate marker. Whether it should be checked and how it is used depend on age, risk, history and the proposed treatment.³

Credit where it's due: the published panel includes cause-focused markers such as LH and FSH, not just testosterone. It also includes PSA and hematocrit. But a marker list does not prove assay quality, confirm a diagnosis, or show that every patient gets all the testing and monitoring they need.¹⁹³

Here's the catch, and it's the most important clinical point on this page.

The Endocrine Society's guideline is specific. Diagnosis requires symptoms or signs plus consistently low testosterone, confirmed with repeat morning fasting testing and an appropriate assay. Its July 2026 statement calls for at least two early-morning, fasting testosterone tests. A threshold near 300 ng/dL is commonly used, but no single cutoff is a diagnosis by itself.³²¹

Hims' kit contains two Tasso devices, and Hims instructs you to ship both samples the same day you collect them. Two devices in one sitting do not establish two measurements on separate mornings. We could not confirm from Hims' public materials whether a separate diagnostic repeat test is routinely required and included.¹

So ask. Word it exactly like this:

"Do both samples in my kit come from one collection session? If an initial result is low or borderline, is a separate early-morning confirmatory test required, and is it included?"

A first low or borderline result calls for clinical review and appropriate confirmation, not an automatic checkout button. If you work nights, have been acutely ill, or already use hormone treatment, tell the ordering clinician: collection timing and interpretation may need to be adjusted.³

One genuinely useful detail: Hims states that follow-up lab kits are free. It publishes checks at 3 months and 15 months into treatment, with the schedule resetting after any dose change. If you're comparing total cost against providers who charge for every retest, that matters. This published schedule is not a promise that waiting a year between tests is right for you; ask for your own monitoring plan and the process for an earlier check.¹⁹

There's also a separate Men's Core Panel, offered without an obligation to buy treatment. Its page lists hormones, cholesterol, hematocrit, TSH and vitamin D, and states that returning the kit within 30 days earns a $69 credit toward a future eligible purchase. The page uses both "20+" and "22" markers, while its category counts add to 21. Confirm the purchase price, exact panel and collection instructions before ordering; the visible credit is not proof of today's kit price, and this separate panel is not automatically a substitute for the $94 treatment-entry testing.²²

If you've never had low testosterone properly evaluated, you're not ready to choose a treatment plan yet. Start with a clinician who can assess your symptoms and arrange appropriate testing, including your own doctor through your insurance when covered. Our guide to blood tests for TRT explains what to ask about collection, confirmation and follow-up. To compare care routes, map it with Find My TRT Path.

---

Does Hims testosterone treatment actually work?

Enclomiphene raises testosterone levels in randomized trials of selected men with secondary hypogonadism. Symptom improvement is a separate outcome: FDA reviewers in 2022 and the European Medicines Agency in 2018 found that the studies they reviewed had not established meaningful symptom benefit. Later pooled SERM research does not establish results for Hims' specific compounded combinations.⁶⁷⁸

This is the section we'd want to read if we were you, so we're going to be precise.

On the number going up: the evidence is real. A 2025 systematic review and meta-analysis pooling 10 randomized controlled trials across 819 men reported an average increase in total testosterone of roughly 274 ng/dL versus placebo. But that result pooled clomiphene and enclomiphene studies — it is not an enclomiphene-only estimate, a Hims trial, or a promise for an individual. Enclomiphene studies within the evidence base also found rises in testosterone, LH and FSH in selected men with secondary hypogonadism.⁶

On feeling better: two regulators found the case was not made in the studies they reviewed.

In June 2022, the FDA's Pharmacy Compounding Advisory Committee reviewed enclomiphene citrate for raising testosterone, LH and FSH in secondary hypogonadism. FDA reviewers concluded that the clinical trials then available had not demonstrated clinically meaningful improvement in the symptoms or signs of the condition, and noted that FDA-approved therapies with established efficacy already exist. The committee voted 8–4 against recommending enclomiphene citrate for the 503A bulks list. That was an advisory recommendation, not a final FDA ban.⁷²³

The current status matters too. FDA's list updated May 14, 2026 still places enclomiphene citrate in Category 1 — bulk drug substances under evaluation. That is neither FDA drug approval nor an assurance that every compounded prescription or pharmacy meets the law. Hims' compounded preparations remain unapproved finished products.¹⁸¹⁴

Four years earlier, the European Medicines Agency recommended refusing marketing authorization for EnCyzix, an enclomiphene product. Its assessment of the main studies concluded that the package did not adequately demonstrate improvement in meaningful symptoms, and that venous blood clot risk remained a concern.⁸

Two regulators. Different continents. Different processes. Same conclusion about the same gap.

Newer evidence does not erase that distinction. The 2025 review found mixed symptom findings across SERM studies, with differences in drugs and outcome measures. A 2026 British Society for Sexual Medicine position statement describes enclomiphene as a potential option for selected men, but does not recommend routine use outside specialist settings because the evidence remains limited. Neither publication tested Hims' current supplement blends.⁶⁴

What that means for you, practically: a higher testosterone number is a plausible treatment effect, not a personal guarantee. Whether the fatigue lifts, the drive comes back, or the fog clears is a separate question — and a higher hormone level is not the same thing as feeling like yourself again. Ask how your clinician will judge symptom benefit as well as lab results.⁶⁴

An individual report of feeling better can be real without proving that the medicine caused it or that another patient will have the same result. It cannot settle the controlled-trial question.

Two more boundaries worth holding:

Studying an ingredient is not the same as studying the product. Enclomiphene-specific trials tested enclomiphene, while the pooled analysis also included clomiphene. Hims sells enclomiphene blended with supplements, and in one version with tadalafil. A trial of one ingredient doesn't establish results for a different combination.⁶¹²¹⁰

If you take the tadalafil version and your erections improve, that doesn't prove your hormones were the problem. Tadalafil is a well-established erectile dysfunction medicine with its own approved use. It works on blood flow. Feeling better in that specific way may tell you nothing at all about your testosterone.⁹

We're not telling you enclomiphene doesn't work. We're telling you what the strongest available evidence does and doesn't show, so that if you spend $990 you're doing it with your eyes open about what you're buying.

---

Will Hims testosterone treatment affect my fertility?

Exogenous testosterone suppresses the body's own hormone signaling and can reduce sperm production. Enclomiphene raises LH and FSH, which is why it is considered for some men whose fertility plans matter. No provider can promise preserved or restored fertility, and near-term conception plans belong with a clinician who specializes in them.³⁴⁶

The mechanism is straightforward. Testosterone from outside tells your brain to stop sending the signal — and that same signal drives spermatogenesis, the process of making sperm. Turn the signal down and sperm production usually falls with it. That's why FDA-approved testosterone products carry fertility warnings.¹³

Enclomiphene does the reverse. It turns the signal up. That's the design intent, and there's supporting research behind it.⁴⁶

But design intent is not a guarantee, and we're not going to pretend otherwise. A favourable semen analysis doesn't promise a pregnancy. A fertility-sparing mechanism doesn't mean fertility is protected in your case. And if you and your partner are trying to conceive now — not someday, now — that decision belongs with a reproductive urologist, urologist or endocrinologist before it belongs with any online platform, including the ones we recommend elsewhere on this site.³⁴

The Endocrine Society recommends against testosterone therapy in men planning fertility in the near term. Fertility goals belong in the clinical evaluation before treatment, not after a prescription has been chosen.³

If fertility is the live question, the next step should be an appointment, not a checkout. Our guide to TRT and fertility covers what to ask.

---

What are the side effects, and what should you watch for?

Hims lists elevated estradiol, headache and abdominal discomfort among reported enclomiphene effects, and lists other possible effects and warnings for its compounded blends. Vision changes, possible blood clots and serious mood or other new symptoms need medical attention. The evidence is not large or long enough to establish rare-event rates or long-term safety for Hims' combinations.¹²¹⁰⁸⁴

Hims' own published safety information is useful, but it is not an FDA-approved label for the blend:

Reported or listed possible effects: headache · hot flashes or flushing · mood changes or irritability · nausea or stomach upset · breast tenderness · fatigue · elevated estradiol. These are not all established as common effects of enclomiphene itself; Hims also draws on clomiphene research and the other ingredients in its blends.¹²¹⁰

Get medical care right away for: vision changes, floaters or vision loss · severe or persistent headaches · signs of blood clots such as new leg swelling, chest pain or shortness of breath · severe mood changes, mania or other new psychiatric symptoms · signs of liver problems such as yellowing skin or eyes, dark urine or significant abdominal pain · rapid unexplained swelling or weight gain. New depression also warrants prompt clinician contact; thoughts of harming yourself need urgent or emergency help.¹⁰

Lab findings need a clinician, not self-interpretation. A high red blood cell count, raised PSA or another abnormal result needs follow-up from the treating clinician. Those findings cannot be judged from how you feel, and a screening result is not a cancer diagnosis.³⁸

A history of blood clots, significant heart or liver disease, serious psychiatric illness, or prostate or breast cancer should be discussed before any prescription decision. EMA's assessment raised clot concerns and identified limitations in the safety evidence. Hims' blend safety information also lists important exclusions and cautions; the exact ingredients and your medical history matter.⁸¹⁰

If your prescription includes tadalafil, the safety picture changes and gets more specific. Tadalafil must not be combined with nitrates or with guanylate cyclase stimulators such as riociguat — that combination can cause a dangerous drop in blood pressure. Other medicines matter too. Give the prescribing clinician and the dispensing pharmacist your complete medication list, including anything over the counter.⁹

Emergency, not a message queue: an erection lasting more than four hours needs emergency care. Sudden vision or hearing changes need prompt medical attention. Severe chest pain or sudden difficulty breathing means call emergency services.⁹¹⁰

One honest note on the evidence base: small, short studies can miss rare serious events. That is a description of a limited evidence base, not proof of safety. Five-year safety for Hims' particular compounded blends has not been established by the studies cited here.⁸⁴

---

Is Hims testosterone available in my state?

Hims' testosterone product page states that Testosterone Rx is not available in all 50 states and does not publish a list of which states are served. A separate Hims article states that most medications can be ordered through the platform in all 50 states and Washington, D.C., while noting that some states restrict at-home lab testing and which testosterone products are available. Hims also states that a live video visit with a provider is required in some states, without naming them.¹²¹¹⁹

Those Hims statements cover different scopes, so don't treat the platform-wide claim as your answer. Confirm that the exact testosterone-related product and its testing process are available where you will be located for care, not just that another Hims medicine is sold in your state.¹²¹

There's another detail worth asking about before you pay: when, and how, you will speak with the clinician.

Hims' testosterone FAQ says a video visit is required in some states and places that step after lab results. Separately, the FTC complaint alleges that some platform customers in states without real-time consultation requirements received prescribing decisions without further interaction after their forms were reviewed. That is an allegation about the broader platform, not proof of what will happen in a particular testosterone intake.¹²⁴

If a live conversation before payment is important to you, get the sequence in writing. Ask whether it happens before the lab-kit charge, before the medication charge, or only after results. A required video visit is not, by itself, proof of better care; the evaluation and follow-up still matter.

The sequence to use, in order: ask Hims about your state and exact product · confirm the lab and clinician-visit steps · ask which charges come before those steps · save the answer before paying. Hims' support page explains how non-subscribers can submit a question. To work out the broader care route first, map your state and situation with Find My TRT Path.

---

Who would prescribe, dispense, and manage your care?

Hims is the platform; its terms identify medical groups and clinicians as the providers of care, and pharmacies as the dispensers. A public list of partners does not identify the clinician or pharmacy assigned to you, so confirm those names before treating a brand reputation as a license check.²⁰

Sources: Hims' terms, telehealth consent, and Medical Groups Notice of Privacy Practices. These are published policies, not a test of service delivery.

For records, use the written-request contact in the medical groups' notice, under “Right to Inspect and Copy.” Ask for complete laboratory reports with collection dates and methods, clinical notes and prescription details — not just an app summary. Save them before a care transfer; do not assume changing providers guarantees a refill.

Privacy also has more than one layer. Hims' terms distinguish the platform from medical groups and other entities, and say HIPAA does not automatically cover every platform interaction. Read the Hims privacy policy alongside the medical groups' notice rather than treating a privacy slogan as a complete answer.²⁰²⁵

---

Is Hims legit — and what does the FTC lawsuit actually say?

Hims & Hers Health, Inc. is a real, publicly traded telehealth company that has operated since 2017. It is also the defendant in a federal enforcement action filed July 29, 2026 by the Federal Trade Commission, joined by Utah and by California through Los Angeles County Counsel, alleging deceptive billing, inadequate refill disclosure, obstructive cancellation and sharing of sensitive health information with advertising platforms. These are allegations, not findings of liability; Hims denies them.²⁶²⁷

We read the complaint. Here's what's in it, and what isn't.

The case: Federal Trade Commission et al. v. Hims & Hers Health, Inc., No. 3:26-cv-07871, U.S. District Court for the Northern District of California, filed July 29, 2026. The claims run under Section 5 of the FTC Act, the Restore Online Shoppers' Confidence Act, California's false advertising, unfair competition and automatic renewal laws, and Utah's consumer sales practices act.²⁴

The four allegation groups, in plain English:

1. Charged before you meant to be. The complaint alleges Hims advertises "free consultations" and displays "Pay $0 today" at the end of the intake, but that most customers never get a consultation — a provider reviews the form, prescribes, and the card is charged immediately, before the customer knows what was prescribed.²⁴
2. Refills arrive earlier than you'd expect. The complaint alleges Hims routinely charged the first refill 10 days before the schedule the customer selected, and required cancellation two days before that earlier date to avoid the charge.²⁴
3. Cancelling was made hard. The complaint alleges that after April 2023, the online cancel option was hidden behind a button labeled "Add/remove items from order," with the word "cancel" appearing only several steps later, followed by three to ten retention survey screens.²⁴
4. Health data went to advertisers. The complaint alleges Hims shared customer lists and website activity with Meta and Snap, and placed advertising pixels from at least fourteen platforms including Microsoft, Pinterest, Reddit, TikTok and X, despite promising a "100% online, private, and secure" process.²⁴

Here's a limit in the complaint that matters. It lists Hims' expanded product categories as sexual health, hair loss, skin, mental health and weight loss. Testosterone is not among the categories named, and the complaint does not specifically identify the testosterone program. That does not establish that all the alleged conduct ended before the program launched.²⁴

What is at issue is the platform's intake, subscription and data-handling practices. Those are sensible questions to ask before choosing any Hims program, but we did not test whether the testosterone checkout uses the same flow. That's the honest way to hold it: not "Hims is being sued over testosterone," and not "this has nothing to do with you."²⁴

Hims' response, same day, quoted fairly. The company said the lawsuit "disregards substantial evidence we provided the FTC during its nearly three-year investigation, ignores established state laws and industry standards in telehealth, and contorts the law to try to manufacture claims." It called the action "an effort to generate headlines at our expense" and said it will "vigorously defend" itself.²⁷

The FTC's own standard note applies: a complaint means the Commission has reason to believe the law is being violated. The case will be decided by the court. We did not verify a final judgment or settlement in the public sources checked for this article.²⁶

Two customer complaints quoted verbatim in the FTC's filing, because they describe the exact friction this section is about:

"I was told that I would be able to speak with a doctor in a few days and that nothing would be charged to my card that day."

"I was prescribed and enrolled in a recurring subscription before knowing what the prescription dosage would be."

These are individual complaints quoted in a federal court filing. They describe those people's experiences. They are not a measured sample, not evidence of what will happen to you, and not evidence about the testosterone program specifically.²⁴

---

How can you sign up for Hims without getting stuck?

Two habits protect you: screenshot the payment screen before you click, because it holds your plan length, renewal cadence and cancellation deadline; and calendar your cancel-by date the same day, counted backwards from the renewal processing date rather than from the end of your supply. Use the actual dates in your account and plan terms; the historical example below is not a testosterone-plan deadline.²⁰²⁸

The FTC complaint reproduces a Hers anxiety-and-depression checkout disclosure. The quoted terms are the company's language, not a testosterone quote:²⁴

"...you are purchasing an automatically-renewing subscription and will be charged $147 for your first 90 days supply and $147 every 90 days thereafter until you cancel. Your second shipment will be charged and shipped 10 days early to prevent any gaps in your treatment. Ongoing shipments may be charged and shipped up to 2 days early... Your subscription(s) will renew and your prescription will be refilled unless you cancel at least 2 days before the next processing date."²⁴

Important: that screenshot is from a different product line, not the testosterone checkout. We could not confirm the same 10-day term appears on a testosterone plan. Hims' current general terms say the first renewal may be charged early, later renewals may be charged or shipped up to two days early, and cancellation must precede the applicable processing date by at least two days.²⁰

The arithmetic below shows why an early processing date matters. It assumes a 10-day early renewal and a two-day cancellation lead time solely to illustrate the quoted example:

Illustrative arithmetic only: supply days minus 10, then minus 2. These are not verified Hims testosterone deadlines. Three, five and ten calendar months are not necessarily 90, 150 and 300 days. Confirm the actual dates on your own checkout screen and account.

A cancel-by date can come before the day you expect to run out of medication. That's the difference between stopping a future renewal and finding that it is already processing.

There's also a testosterone-specific wrinkle. Hims' support documentation gives separate instructions for testosterone customers whose labs have been ordered but who have not yet received a prescription — that stage is handled by contacting support rather than through the standard account cancel flow. Turning off a different subscription won't necessarily stop it.²⁸

Which cancellation and refund rule applies at your stage?

Published policies checked September 14, 2026; no cancellation or refund request was tested.²⁸²⁰²

Hims' current website instructions are: Subscriptions → Manage → Additional Options → Manage subscription → Discontinue plan → Cancel Subscription, then finish the cancellation steps. Some treatment types instead use an auto-renewal control under Adjust my plan. Repeat the process for each subscription you intend to cancel.²⁸

Six things to do, in order:

1. Screenshot the payment screen before you click. Save the plan, credit and renewal terms.
2. Put the cancel-by date in your phone the same day, counted back from the processing date.
3. Cancel in writing and keep the confirmation.
4. Ask the confirmation to specify which orders stopped and which remain active.
5. Keep the billing records you would need to question an incorrect charge. A payment dispute is not a substitute for canceling the subscription.
6. Save every order confirmation email.

Before you hand any online testosterone provider a card, there are questions worth asking — and answers that should make you pause. We've put ours below. It works on Hims, on the providers discussed elsewhere on this site, and on anyone else.

Questions to get answered before you pay

The product

• What is the full name and ingredient list of what you're proposing? Does it contain testosterone, enclomiphene, tadalafil, or only support ingredients?
• Is this compounded or a specific FDA-approved product? Which pharmacy will compound and dispense it, and how do I reach their pharmacist?

The testing

• Do both samples in my kit come from one collection session? Is a separate early-morning confirmatory test required when the first result is low or borderline?
• Is that repeat test included? Which lab and assay are used, and what collection instructions apply to me?
• What do my LH and FSH results mean in the context of my history, and is further cause-focused testing needed?

The money

• What is charged today, and what period does it cover?
• What happens to my $94 if a provider reviews my results and doesn't prescribe anything? If treatment is prescribed, when and how is the credit applied?
• What is the exact next processing date and amount? Can a charge process earlier than the date I first see?
• What is refundable at my exact stage — kit ordered, results in, prescribed, shipped?

The care

• Who is my treating clinician, and where can I verify the license?
• Is a live video visit required in my state?
• What is my written monitoring plan, and what would trigger an earlier check?
• How do I get copies of my lab and clinical records?

The decision

• Given my fertility plans and my other medicines, is this the right option — and what's the plan if it doesn't work?
• What happens to follow-up care, medication charges and unused medication if the plan changes or the treatment is not helping?

If a provider won't put the money answers in writing, that tells you something useful for free.

Have the product, clinical questions and payment terms clear enough to continue? Review Hims' current testosterone options and plan terms → This opens Hims' public product information, not a promise of eligibility or a prescription.

---

What should you check in Hims testosterone reviews?

Check the exact product, the date of the price, the evidence behind the result claim and the cancellation terms. A review can describe one Hims product accurately and still answer the wrong question about another.

This is our claim-check matrix, assembled from product pages, pricing, the launch announcement, FDA materials and the exact product label. It checks claims, not customer satisfaction or treatment outcomes.^{11211216131814}

The point is not to assume bad faith. On a decision involving a $990 plan, the product name, terms and evidence need to line up. You can check the current offer yourself using the “Coming” search described near the top.

And here's what we didn't do. We did not use a Hims testosterone account, complete its intake, test a checkout, receive a lab kit or cancel a subscription for this assessment. This page is based on public provider pages and policies, the FTC's public court filing, FDA and advisory committee documents, professional guidance, peer-reviewed research and federal regulatory notices checked for this assessment. Where we couldn't confirm something, we said so instead of guessing. That's also why there's no star rating on this page: we don't have the firsthand experience or the representative data that would make a number honest.

---

If Hims isn't the right fit, what is?

Hims' current published testosterone offer is enclomiphene, not testosterone itself. If your clinician recommends actual testosterone, the realistic routes include your own clinician and pharmacy or an online service whose exact product, testing and state access you can confirm. A different enclomiphene provider answers a separate question: which service to use after that treatment approach has been clinically assessed.¹³

Start here: your own doctor and your own pharmacy

We're putting this first because it lets you check your existing insurance and pharmacy benefits before paying for a separate subscription.

Ask your existing clinician or health plan about coverage for evaluation, repeat morning tests and a pharmacy prescription if treatment is appropriate. An FDA-approved generic testosterone product may offer a different cost and dispensing path from a cash-pay compounded program, but your formulary, deductible and clinical needs decide the bill. A local prescription still needs ongoing care, monitoring and valid refills; it does not become permanent access simply because it is held at a pharmacy.³¹³

If online-versus-local is the real question you're weighing, our guide to online TRT clinics versus a local doctor walks through the tradeoffs.

If you want the enclomiphene approach, but not necessarily Hims

Hims isn't the only place offering enclomiphene, and plan structures vary. If the mechanism is what appeals to you — a pill rather than testosterone replacement — compare across the category before committing ten months to anyone. Fertility-related fit still belongs with a clinician, not a marketing label. See best enclomiphene providers.⁴

If your clinician recommends actual testosterone: Male Excel

Disclosure: Male Excel is a commercial partner of TRT Provider Guide. The links here open its public information pages, not paid tracking links. We earn nothing if you choose Hims.

The honest limitation first. Male Excel's pricing subdomain describes a blood-spot test measuring five hormone levels, not a full venous lab panel. Hims publishes a nine-marker panel. Those counts alone do not establish which evaluation is clinically adequate. And when we checked on September 14, 2026, Male Excel's two public pricing pages published different membership rates: $30 per 30 days on its HRT subdomain and $99 per month on its main site.²⁹³⁰¹⁹

If a standard venous draw and one unambiguous price are what you need before handing over a card, resolve those points before choosing Male Excel. Your own clinician is another route for a cause-focused evaluation and written cost estimate.³

Here's the useful part of its itemization. Male Excel publishes separate cost components, but the two pages cannot be mixed into one verified quote:

Provider-published figures checked September 14, 2026, not checkout quotes. These are different page presentations, not a verified menu of interchangeable prices. The subdomain's supply examples are pricing descriptions, not dosing advice.²⁹³⁰³¹

The headline difference between $30 and $99 is $69. Multiplying that by 12 gives $828, but that is not a verified annual bill or saving: one page says 30-day billing, the other says monthly, and the actual applicable plan remains to be confirmed.

On the main page's advertised monthly equivalents, medication plus membership is $219 for the injection plan ($120 + $99) or $231 for the cream plan ($132 + $99), before shipping and any other applicable charges. Initial fees, prescription-dependent use and actual billing dates still prevent a verified first-year cash total.³⁰

Because costs depend on the prescribed treatment and quantity, ask for your actual medication, membership, testing and shipping costs before you commit, and ask what happens to the price if the prescription changes. An itemized page helps you ask that question; it does not answer the conflict between the two pages.³⁰³¹

Two more real differences need careful wording. Male Excel says treatment may be eligible for FSA/HSA reimbursement, while Hims says it does not accept those plans as direct payment; neither statement guarantees that your whole bill qualifies. Male Excel also offers testosterone cypionate, which is actual testosterone. That ingredient name alone does not prove your dispensed vial is an FDA-approved finished product: confirm the manufacturer, product identification and whether it is compounded. Male Excel explicitly describes its Lipoderm cream as compounded; that cream is not FDA-approved.³¹¹⁵¹⁴

One thing to know: Male Excel's advertised plan bundles a desiccated thyroid tablet alongside the testosterone. Ask why it is proposed in your case and whether it is required in the quoted package; thyroid treatment is a separate clinical decision, not proof of a better TRT plan. Its FAQ also says it does not provide letters of medical necessity, which matters if your reimbursement process needs one.³⁰³¹

Does that sound like your situation — your clinician recommends testosterone and you want an itemized quote? Review Male Excel's public pricing and treatment options. First ask which membership rate applies, what testing and pharmacy are included, and whether the thyroid medicine is clinically indicated. Get the answers before paying.

Taurus Meds is a second online option to research after the Hims question is answered. Its inspected campaign page advertises a $49 test and consultation and $149 per month for TRT, and describes Labcorp or Quest testing, with an at-home option for people more than 50 miles from a service center. Those are provider-published campaign claims, not a verified all-in first-year quote or confirmation of your exact medicine and pharmacy. Its homepage promotes a different free-test offer, so do not combine the two. Read Taurus Meds' published offer and confirm the applicable promotion, repeat testing, required fees and care terms before committing.³²³³

One fee conflict needs a written answer. The campaign describes its price as all-inclusive, but Taurus' separate terms state a recurring $17.99 membership fee per billing period. Confirm whether that clause applies to the TRT offer; do not assume it is monthly or already included in $149.³²³⁴

If you're still not sure

Product type, state rules, fertility plans and insurance status pull in different directions, and a general answer can't resolve yours. Map your situation with Find My TRT Path →

---

Who should not choose Hims as the starting point?

Enclomiphene needs a responsive hormone-signaling system and testicles; it is not a remedy for testicular failure. Do not use a prepaid treatment plan as a substitute for a clinical evaluation; near-term fertility or complex health risks may need specialist care first. Insurance billing and direct HSA/FSA payment are separate practical fit issues.³⁴¹

We'd rather you leave this page and get the right care than sign up for the wrong thing. Any one of these can be enough to change the next step:

• Your low testosterone is the primary type — testicular failure. A clinician needs to select treatment for that cause; enclomiphene does not repair failed testicular function.³⁴
• You've never had low testosterone properly evaluated. Get a clinical assessment and appropriate repeat morning tests before committing to treatment.²¹
• You're trying to conceive in the next few months. See a reproductive urologist first.³
• You have a history of blood clots or significant cardiac or liver disease. These require a risk review for the specific proposed medicine.⁸¹⁰
• You have a prostate or breast cancer history, or a known PSA or hematocrit problem. That needs assessment by a clinician who can arrange the appropriate examination, testing and specialist care.³
• You have untreated severe sleep apnea or a recent major cardiovascular event. Clinician first.³
• You need insurance, Medicare or Medicaid billing, or direct HSA/FSA payment. Hims does not offer those payment routes. Possible HSA/FSA reimbursement for a qualified expense is a different question; check it before paying.¹²⁰⁵
• Your symptoms could be something else. Thyroid disease, depression, anemia and sleep disorders can overlap with a tired-and-flat picture. That's genuinely worth investigating — and it's an argument for a cause-focused clinical evaluation, not simply the biggest blood panel.³²¹
• You want testosterone for physique or performance. That isn't what this page is for, and it is not a basis for a medical TRT recommendation.

---

What did we actually verify?

What we actually verified — September 14, 2026. This is a public-source assessment, not a hands-on treatment review. We checked what the documents say and separated that from what only a patient's care and checkout records could establish.

Checked directly: Hims' testosterone storefront, product and safety pages, pricing guide, comparison article, terms, cancellation instructions, telehealth consent and medical groups' privacy notice · the FTC complaint in No. 3:26-cv-07871 and the FTC announcement · Hims' public response · FDA compounding materials, 2022 advisory materials and its May 2026 category list · EMA's EnCyzix assessment · the Endocrine Society guideline and July 2026 statement · the 2025 SERM meta-analysis and 2026 British Society for Sexual Medicine position statement · the DEA/HHS Fourth Temporary Extension · prescribing information for Kyzatrex and Cialis · IRS guidance · Male Excel's two pricing pages and FAQ · Taurus Meds' campaign page, homepage and membership-fee terms.

Publication verified; service not independently tested: Hims' listed ingredients · three published plan rates · $94 kit and conditional credit · published nine-marker panel · stated free follow-up testing at 3 and 15 months · no insurance billing or direct HSA/FSA payment · current “Coming in 2026” labels · Male Excel's conflicting price presentations · Taurus Meds' published campaign prices and separate membership-fee clause. These are provider-stated facts, not proof of what every patient receives.^121930293234

Independently checkable records and calculations: the FTC filing, its allegations and the company's denial · FDA's nonapproval and current under-evaluation status for enclomiphene citrate · the advisory vote's limited legal meaning · the pooled drugs and outcomes in the meta-analysis · the federal extension's dates and conditions · the plan-value and conditional cash-flow arithmetic.^24271823617

Could not confirm for an actual patient: Hims' applicable state list, assigned clinician and pharmacy, exact diagnostic-repeat requirement and fee, credit timing, treatment-declined refund decision, testosterone-specific first-renewal date and amount, individualized monitoring and response times, or medical-record delivery time. We also did not confirm Male Excel's applicable checkout rate or a complete Taurus Meds first-year quote. The public article does not turn those gaps into assurances.

We separate four things throughout this page: verified source records and arithmetic, provider-stated facts about the service, customer-experience signals that describe individual reports and prove nothing about typical outcomes, and editorial judgment — our conclusions about fit, drawn from the evidence.

That's the same method we apply to every provider. You can read it in full: How We Review TRT Providers.

What would change this assessment: confirmed injectable or oral testosterone access at Hims · a change to its plan rates or kit credit · a material FTC case outcome · a change in enclomiphene's FDA or compounding status · new evidence on meaningful symptoms or long-term safety · a change to federal or state prescribing rules.

See our affiliate disclosure, authorship and medical review policy, editorial standards, privacy policy and corrections process.

---

What else should you know about Hims testosterone?

The main remaining questions are about product identity, cost, testing and the point at which you can cancel. These answers refer to the public offer and policies checked September 14, 2026, not an individual prescription or checkout quote.

Is Hims testosterone the same as TRT? No. Hims' current testosterone program uses compounded enclomiphene, which stimulates your body's own testosterone production. Testosterone replacement therapy adds testosterone from outside. Hims states it does not currently offer TRT injections.¹

How much is Hims testosterone per month, really? Hims publishes $199 on a 3-month plan, $139 on a 5-month plan, or $99 on a 10-month plan that must be paid upfront and in full — a gross plan value of $990. The initial lab kit is $94, with a stated treatment credit if you're deemed eligible. Confirm the net charge and credit timing; do not automatically add $94 to a credit-adjusted plan total.²¹

Does Hims prescribe testosterone injections? Hims' current public FAQ says it does not offer access to TRT injections. Injectable testosterone cypionate and oral Kyzatrex are both marked "Coming in 2026" on the storefront as of September 14, 2026; we did not confirm live Hims enrollment for either.¹

Is enclomiphene FDA-approved? No. There is no FDA-approved enclomiphene drug. Hims' compounded preparations are not FDA-approved finished products. FDA's May 2026 list still includes enclomiphene citrate among bulk substances under evaluation; that is not an approval or a blanket ban. Compounded is not the same as approved, generic or equivalent.¹⁴¹⁸⁷

Does Hims testosterone treatment actually work? Trials show enclomiphene can raise testosterone in selected men. The often-quoted 2025 result of about 274 ng/dL above placebo came from an analysis of 10 trials in 819 men that pooled clomiphene and enclomiphene, not a Hims trial. Meaningful symptom benefit and safety for Hims' exact combinations are not established by that pooled hormone result.⁶⁷⁸

How long does it take to work? Enclomiphene studies have measured hormone changes over weeks to months. That is a lab-response timeline, not a reliable promise for energy, mood, libido or erections. Ask your clinician when both symptoms and labs will be reviewed, and how a lack of benefit will be handled.⁶⁴

Do I need blood work before Hims will prescribe? Yes. Hims requires a lab kit before a provider can prescribe, and states the panel covers nine biomarkers including total and free testosterone, LH, FSH, PSA and hematocrit.¹⁹

Does Hims take insurance, HSA or FSA? Hims does not bill insurance, and its testosterone FAQ says it does not accept HSA/FSA plans as payment. That does not decide whether an itemized expense qualifies for later HSA/FSA reimbursement. Check the precise expense and required documentation with your administrator before relying on reimbursement.¹²⁰⁵

Which states is Hims testosterone available in? Hims states Testosterone Rx is "not available in all 50 states," but we did not confirm a product-specific state list. Ask Hims about your state, the exact formula, the lab process and any required video visit before paying. Entering a ZIP code alone is not a guarantee of a complete availability or eligibility answer.¹²¹

Will I get my $94 back if I'm not prescribed anything? A refund is not guaranteed by the stated treatment-credit policy. Hims says the kit fee is credited toward treatment if you're deemed eligible, while its general testing terms describe refunds as case-by-case. Ask for the specific $94-kit rule when treatment is declined, before ordering.²²⁰

Is Hims being sued? Yes. The FTC, Utah and California through Los Angeles County Counsel filed the July 29, 2026 action discussed above. These are allegations, not findings of liability, and Hims denies them. The complaint does not specifically name the testosterone program.²⁶²⁴²⁷

Can I cancel after paying for labs but before getting a prescription? Hims' support documentation gives a separate instruction for that stage — contact support directly rather than using the standard account cancel flow. Confirm in writing which orders and future charges your request stops.²⁸

Can I stay on enclomiphene long term? Some patients may receive ongoing treatment, but long-term safety for Hims' specific compounded blends is not established by the short-term trials discussed here. Ask the treating clinician about the reason for continued treatment, symptom benefit, monitoring and alternatives; do not change a prescription based on this page.⁴⁸

---

Still not sure which TRT care route fits you? Use our free Find My TRT Path tool.

Footnotes

1. Hims, testosterone storefront and FAQs. Current published offer, 10-month payment requirement, collection process and payment/state limitations. Checked September 14, 2026. ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷ ↩⁸ ↩⁹ ↩¹⁰ ↩¹¹ ↩¹² ↩¹³ ↩¹⁴ ↩¹⁵ ↩¹⁶ ↩¹⁷ ↩¹⁸ ↩¹⁹ ↩²⁰ ↩²¹ ↩²² ↩²³ ↩²⁴ ↩²⁵ ↩²⁶ ↩²⁷ ↩²⁸ ↩²⁹ ↩³⁰ ↩³¹

2. Hims, Enclomiphene Price. Provider-published rates, initial lab charge and stated credit. Checked September 14, 2026. ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷ ↩⁸ ↩⁹ ↩¹⁰ ↩¹¹ ↩¹² ↩¹³

3. Endocrine Society, Testosterone Therapy in Men With Hypogonadism guideline. Symptoms/signs plus consistently low accurately measured testosterone, repeat morning fasting confirmation, cause evaluation, fertility and safety recommendations. Checked September 14, 2026. ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷ ↩⁸ ↩⁹ ↩¹⁰ ↩¹¹ ↩¹² ↩¹³ ↩¹⁴ ↩¹⁵ ↩¹⁶ ↩¹⁷ ↩¹⁸ ↩¹⁹ ↩²⁰ ↩²¹ ↩²²

4. British Society for Sexual Medicine, position statement on the potential use of enclomiphene citrate in male hypogonadism. Published February 13, 2026; World Journal of Men's Health 44(3):480–483. Specialist-setting and evidence-limit qualifications. Checked September 14, 2026. ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷ ↩⁸ ↩⁹ ↩¹⁰ ↩¹¹ ↩¹² ↩¹³ ↩¹⁴ ↩¹⁵

5. IRS, Publication 969: Health Savings Accounts and Other Tax-Favored Health Plans. Qualified-expense payment and reimbursement rules; provider card acceptance does not by itself determine tax qualification. Checked September 14, 2026. ↩ ↩² ↩³ ↩⁴ ↩⁵

6. Clomiphene or enclomiphene citrate for the treatment of male hypogonadism: a systematic review and meta-analysis of randomized controlled trials. Archives of Endocrinology and Metabolism, 2025; DOI 10.20945/2359-4292-2025-0093. Ten trials, 819 participants; pooled clomiphene/enclomiphene evidence, not a Hims trial. Checked September 14, 2026. ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷ ↩⁸ ↩⁹ ↩¹⁰ ↩¹¹

7. FDA, June 8, 2022 Pharmacy Compounding Advisory Committee materials. Enclomiphene review, including clinical-benefit limitations. Historical assessment, not a final compounding prohibition. Checked September 14, 2026. ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶

8. European Medicines Agency, EnCyzix public assessment report. 2018 assessment; benefit–risk discussion and recommendation for refusal, including symptom-endpoint and thromboembolic concerns. Checked September 14, 2026. ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷ ↩⁸ ↩⁹ ↩¹⁰

9. Cialis prescribing information, Eli Lilly. Tadalafil product identity and contraindications with nitrates and guanylate cyclase stimulators, plus priapism, vision and hearing warnings. Checked September 14, 2026. ↩ ↩² ↩³ ↩⁴

10. Hims, Enclomiphene + Tadalafil Supplement Blend: Important Safety Information. Provider-published formulation warnings; not an FDA-approved label. Checked September 14, 2026. ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷ ↩⁸ ↩⁹

11. Hims, Sex Rx + Testosterone Support: Important Safety Information. Separate tadalafil-and-support-ingredients product; no enclomiphene. Checked September 14, 2026. ↩ ↩² ↩³

12. Hims, Testosterone Rx+ with enclomiphene and supplements. Ingredients, unapproved compounded status and program disclosures. Checked September 14, 2026. ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷ ↩⁸

13. Kyzatrex prescribing information. Revised July 2025; FDA reference ID 5622849. Testosterone undecanoate product identity, indications, diagnostic confirmation, monitoring and fertility warnings. Checked September 14, 2026. ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷

14. FDA, Understanding the Risks of Compounded Drugs. Compounded drugs are not FDA-approved; FDA does not verify their safety, effectiveness or quality before marketing. Checked September 14, 2026. ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶

15. DEA, Drug Scheduling. Testosterone is listed as a Schedule III controlled substance. Checked September 14, 2026. ↩

16. Hims & Hers investor announcement, September 10, 2025. Original category launch and planned 2026 testosterone products; marketing claims are not efficacy evidence for the compounded offer. Checked September 14, 2026. ↩ ↩² ↩³ ↩⁴

17. DEA and HHS, Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications. 90 FR 61301; January 1–December 31, 2026, subject to the rule's encounter, prescribing and other legal conditions. Checked September 14, 2026. ↩ ↩² ↩³ ↩⁴

18. FDA, Bulk Drug Substances Nominated for Use in Compounding Under Section 503A. Updated May 14, 2026; page 2 lists enclomiphene citrate under Category 1, substances under evaluation. Checked September 14, 2026. ↩ ↩² ↩³ ↩⁴ ↩⁵

19. Hims, Hims vs. Hone Health. Used only for Hims' own stated nine-marker panel, prices, inclusions and follow-up schedule, not as medical authority or verification of Hone. Checked September 14, 2026. ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷ ↩⁸ ↩⁹

20. Hims, Terms and Conditions. Medical groups, pharmacy relationships, cash-pay terms, general subscriptions, testing refunds and privacy distinctions. Product-specific terms must not be transferred between programs. Checked September 14, 2026. ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷ ↩⁸ ↩⁹ ↩¹⁰

21. Endocrine Society, Statement on Testosterone Replacement Therapy. July 16, 2026; diagnostic confirmation, assay quality and reversible contributors. Checked September 14, 2026. ↩ ↩² ↩³ ↩⁴

22. Hims, Men's Core Panel. Panel descriptions and conditional $69 credit; not a verified current purchase-price quote. Checked September 14, 2026. ↩

23. FDA, June 8, 2022 Pharmacy Compounding Advisory Committee meeting minutes. Enclomiphene recommendation vote: 4 yes, 8 no; advisory action. Checked September 14, 2026. ↩ ↩²

24. FTC et al. v. Hims & Hers Health, Inc., complaint. No. 3:26-cv-07871, filed July 29, 2026. Page 10: Hers anxiety-and-depression checkout image; page 13, paragraph 33: quoted customer complaints. The filing does not specifically identify the testosterone program. Checked September 14, 2026. ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷ ↩⁸ ↩⁹ ↩¹⁰ ↩¹¹ ↩¹² ↩¹³

25. Hims Medical Groups, Notice of Privacy Practices. Right to Inspect and Copy section: written medical-record requests, electronic copies and possible lawful costs. Checked September 14, 2026. ↩

26. FTC, announcement of Hims & Hers enforcement action. July 29, 2026; allegations, plaintiffs and complaint standard, not findings of liability. Checked September 14, 2026. ↩ ↩² ↩³

27. Hims & Hers Responds to FTC Lawsuit. July 29, 2026; the company's denial and response. Checked September 14, 2026. ↩ ↩² ↩³ ↩⁴

28. Hims support, How do I cancel my subscription?. Updated August 25, 2026; account steps, processing-order limit and special instruction for testosterone customers with labs ordered but no prescription. Checked September 14, 2026. ↩ ↩² ↩³ ↩⁴ ↩⁵

29. Male Excel, HRT pricing subdomain. Observed component prices and $30-per-30-days membership; applicability to a new patient not confirmed. Checked September 14, 2026. ↩ ↩² ↩³

30. Male Excel, HRT Costs. Observed main-site consultation, medication and $99 monthly membership prices; shipping extra. Checked September 14, 2026. ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶

31. Male Excel, Frequently Asked Questions. Provider-stated test inclusion, compounded cream, reimbursement and medical-necessity-letter policies; not authority for broad medical efficacy claims. Checked September 14, 2026. ↩ ↩² ↩³ ↩⁴

32. Taurus Meds, testosterone campaign offer. Provider-published $49 test/consultation and $149 monthly claim, lab locations and distant-patient kit option. Not independent proof of clinical care or a complete quote. Checked September 14, 2026. ↩ ↩² ↩³

33. Taurus Meds, homepage. Different free-test promotion observed; do not combine promotions by assumption. Checked September 14, 2026. ↩

34. Taurus Meds, Terms of Use. Membership-fee clause: $17.99 per billing period; applicability to the advertised TRT campaign not established. Checked September 14, 2026. ↩ ↩²